Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

CRAC channels as targets for drug discovery and development.

Stauderman KA.

Cell Calcium. 2018 Sep;74:147-159. doi: 10.1016/j.ceca.2018.07.005. Epub 2018 Jul 18. Review.

PMID:
30075400
2.

Modulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease.

Kounnas MZ, Danks AM, Cheng S, Tyree C, Ackerman E, Zhang X, Ahn K, Nguyen P, Comer D, Mao L, Yu C, Pleynet D, Digregorio PJ, Velicelebi G, Stauderman KA, Comer WT, Mobley WC, Li YM, Sisodia SS, Tanzi RE, Wagner SL.

Neuron. 2010 Sep 9;67(5):769-80. doi: 10.1016/j.neuron.2010.08.018.

3.

Orai1 and STIM1 move to the immunological synapse and are up-regulated during T cell activation.

Lioudyno MI, Kozak JA, Penna A, Safrina O, Zhang SL, Sen D, Roos J, Stauderman KA, Cahalan MD.

Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2011-6. doi: 10.1073/pnas.0706122105. Epub 2008 Feb 4.

4.

Molecular basis of the CRAC channel.

Cahalan MD, Zhang SL, Yeromin AV, Ohlsen K, Roos J, Stauderman KA.

Cell Calcium. 2007 Aug;42(2):133-44. Epub 2007 May 7. Review.

5.

Genome-wide RNAi screen of Ca(2+) influx identifies genes that regulate Ca(2+) release-activated Ca(2+) channel activity.

Zhang SL, Yeromin AV, Zhang XH, Yu Y, Safrina O, Penna A, Roos J, Stauderman KA, Cahalan MD.

Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9357-62. Epub 2006 Jun 2.

6.

STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membrane.

Zhang SL, Yu Y, Roos J, Kozak JA, Deerinck TJ, Ellisman MH, Stauderman KA, Cahalan MD.

Nature. 2005 Oct 6;437(7060):902-5.

7.

STIM1, an essential and conserved component of store-operated Ca2+ channel function.

Roos J, DiGregorio PJ, Yeromin AV, Ohlsen K, Lioudyno M, Zhang S, Safrina O, Kozak JA, Wagner SL, Cahalan MD, Veliçelebi G, Stauderman KA.

J Cell Biol. 2005 May 9;169(3):435-45. Epub 2005 May 2.

8.

Modal gating of human CaV2.1 (P/Q-type) calcium channels: I. The slow and the fast gating modes and their modulation by beta subunits.

Luvisetto S, Fellin T, Spagnolo M, Hivert B, Brust PF, Harpold MM, Stauderman KA, Williams ME, Pietrobon D.

J Gen Physiol. 2004 Nov;124(5):445-61.

9.

A store-operated calcium channel in Drosophila S2 cells.

Yeromin AV, Roos J, Stauderman KA, Cahalan MD.

J Gen Physiol. 2004 Feb;123(2):167-82.

10.

Recent advances in the modulation of voltage-gated ion channels for the treatment of epilepsy.

Cosford ND, Meinke PT, Stauderman KA, Hess SD.

Curr Drug Targets CNS Neurol Disord. 2002 Feb;1(1):81-104. Review.

PMID:
12769636
11.

Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats.

Luo ZD, Chaplan SR, Higuera ES, Sorkin LS, Stauderman KA, Williams ME, Yaksh TL.

J Neurosci. 2001 Mar 15;21(6):1868-75.

12.

Biophysical properties, pharmacology, and modulation of human, neuronal L-type (alpha(1D), Ca(V)1.3) voltage-dependent calcium currents.

Bell DC, Butcher AJ, Berrow NS, Page KM, Brust PF, Nesterova A, Stauderman KA, Seabrook GR, Nürnberg B, Dolphin AC.

J Neurophysiol. 2001 Feb;85(2):816-27.

13.

Characterization of the recombinant human neuronal nicotinic acetylcholine receptors alpha3beta2 and alpha4beta2 stably expressed in HEK293 cells.

Chavez-Noriega LE, Gillespie A, Stauderman KA, Crona JH, Claeps BO, Elliott KJ, Reid RT, Rao TS, Velicelebi G, Harpold MM, Johnson EC, Corey-Naeve J.

Neuropharmacology. 2000 Oct;39(13):2543-60.

PMID:
11044726
14.

Functional consequences of mutations in the human alpha1A calcium channel subunit linked to familial hemiplegic migraine.

Hans M, Luvisetto S, Williams ME, Spagnolo M, Urrutia A, Tottene A, Brust PF, Johnson EC, Harpold MM, Stauderman KA, Pietrobon D.

J Neurosci. 1999 Mar 1;19(5):1610-9.

15.

Structure and functional characterization of a novel human low-voltage activated calcium channel.

Williams ME, Washburn MS, Hans M, Urrutia A, Brust PF, Prodanovich P, Harpold MM, Stauderman KA.

J Neurochem. 1999 Feb;72(2):791-9.

16.

Fluorescence techniques for measuring ion channel activity.

Veliçelebi G, Stauderman KA, Varney MA, Akong M, Hess SD, Johnson EC.

Methods Enzymol. 1999;294:20-47. No abstract available.

PMID:
9916221
17.

Characterization of human recombinant neuronal nicotinic acetylcholine receptor subunit combinations alpha2beta4, alpha3beta4 and alpha4beta4 stably expressed in HEK293 cells.

Stauderman KA, Mahaffy LS, Akong M, Veliçelebi G, Chavez-Noriega LE, Crona JH, Johnson EC, Elliott KJ, Gillespie A, Reid RT, Adams P, Harpold MM, Corey-Naeve J.

J Pharmacol Exp Ther. 1998 Feb;284(2):777-89.

PMID:
9454827
18.

Rat group I metabotropic glutamate receptors inhibit neuronal Ca2+ channels via multiple signal transduction pathways in HEK 293 cells.

McCool BA, Pin JP, Harpold MM, Brust PF, Stauderman KA, Lovinger DM.

J Neurophysiol. 1998 Jan;79(1):379-91.

19.
20.

Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist.

Sacaan AI, Reid RT, Santori EM, Adams P, Correa LD, Mahaffy LS, Bleicher L, Cosford ND, Stauderman KA, McDonald IA, Rao TS, Lloyd GK.

J Pharmacol Exp Ther. 1997 Jan;280(1):373-83.

PMID:
8996218
21.

(S)-(-)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine maleate (SIB-1508Y): a novel anti-parkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors.

Cosford ND, Bleicher L, Herbaut A, McCallum JS, Vernier JM, Dawson H, Whitten JP, Adams P, Chavez-Noriega L, Correa LD, Crona JH, Mahaffy LS, Menzaghi F, Rao TS, Reid R, Sacaan AI, Santori E, Stauderman KA, Whelan K, Lloyd GK, McDonald IA.

J Med Chem. 1996 Aug 16;39(17):3235-7. No abstract available.

PMID:
8765504
22.

Histamine-induced Ca2+ entry precedes Ca2+ mobilization in bovine adrenal chromaffin cells.

Cheek TR, Murawsky MM, Stauderman KA.

Biochem J. 1994 Dec 1;304 ( Pt 2):469-76.

23.

Quantal Ca2+ mobilization by ryanodine receptors is due to all-or-none release from functionally discrete intracellular stores.

Cheek TR, Berridge MJ, Moreton RB, Stauderman KA, Murawsky MM, Bootman MD.

Biochem J. 1994 Aug 1;301 ( Pt 3):879-83.

24.

Quantal Ca2+ release from caffeine-sensitive stores in adrenal chromaffin cells.

Cheek TR, Moreton RB, Berridge MJ, Stauderman KA, Murawsky MM, Bootman MD.

J Biol Chem. 1993 Dec 25;268(36):27076-83.

25.

Fluoxetine-induced inhibition of synaptosomal [3H]5-HT release: possible Ca(2+)-channel inhibition.

Stauderman KA, Gandhi VC, Jones DJ.

Life Sci. 1992;50(26):2125-38.

PMID:
1608295
27.
28.

Stilbene disulfonic acids. CD4 antagonists that block human immunodeficiency virus type-1 growth at multiple stages of the virus life cycle.

Cardin AD, Smith PL, Hyde L, Blankenship DT, Bowlin TL, Schroeder K, Stauderman KA, Taylor DL, Tyms AS.

J Biol Chem. 1991 Jul 15;266(20):13355-63.

29.

Characterization of substance P receptors in human astrocytoma cells.

Johnson CL, Johnson CG, Stauderman KA, Buck SH.

Ann N Y Acad Sci. 1991;632:410-2. No abstract available.

PMID:
1719890
32.

Effects of EDCF and endothelin on phosphatidylinositol hydrolysis and contraction in rat aorta.

Rapoport RM, Stauderman KA, Highsmith RF.

Am J Physiol. 1990 Jan;258(1 Pt 1):C122-31.

PMID:
2405693
33.
35.
36.

A tachykinin peptide receptor joins an elite club.

Buck SH, Pruss RM, Krstenansky JL, Robinson PJ, Stauderman KA.

Trends Pharmacol Sci. 1988 Jan;9(1):3-5. Review. No abstract available.

PMID:
2854311
37.

Presynaptic serotonin receptors regulate [3H]serotonin release from rat spinal cord synaptosomes.

Stauderman KA, Jones DJ.

Eur J Pharmacol. 1986 Jan 14;120(1):107-9.

PMID:
3948909
38.

Dibutyryl-cyclic GMP stimulation of Ca2+ -ATPase activity in rat brain synaptic membranes.

Stauderman KA, Jones DJ, Ross DH.

J Neurochem. 1985 Sep;45(3):970-2.

PMID:
2993519
39.
40.

Behavioral supersensitivity to beta-phenylethylamine after chronic administration of haloperidol.

Stoff DM, Jeste DV, Gillin JC, Moja EA, Cohen L, Stauderman KA, Wyatt RJ.

Biol Psychiatry. 1984 Jan;19(1):101-6. No abstract available.

PMID:
6538440
41.

An assessment of spectral analysis of amphetamine-induced behavior.

Ellinwood EH Jr, Molter DW, Stauderman KA.

Pharmacol Biochem Behav. 1981 Oct;15(4):627-31.

PMID:
7197374

Supplemental Content

Loading ...
Support Center